ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,415
-1,33%
Bitcoin
69 575,50
-2,62%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. AQSE
  6. Apollon Formularies plc (APOL)

  7. Apollon Formularies plc (APOL) Actualités

APOL

Apollon Formularies (APOL)

Apollon Formularies plc
De:
Trier par:
 Showing the most relevant articles for your search:AQSE:APOL
DateHeureSourceTitreSymboleSociété
03/05/202413h59UK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
01/05/202416h00UK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
20/02/202411h59UK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
02/01/202409h18UK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
05/12/202312h59UK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
21/11/202312h51UK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
29/09/202308h00UK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
19/09/202310h18UK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
03/08/202311h51UK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
02/08/202313h19UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
24/07/202312h00UK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
30/06/202318h32UK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
11/04/202315h00UK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
21/03/202313h00UK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
15/03/202308h00UK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
12/01/202308h00UK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
30/12/202213h37UK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
02/12/202208h00UK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
30/09/202210h50UK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
13/09/202208h02UK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
02/08/202210h11UK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
26/07/202208h00UK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
30/06/202217h29UK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
30/06/202213h33UK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
17/06/202214h23UK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
05/05/202213h07UK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
02/03/202208h01UK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
09/02/202208h00UK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
03/02/202207h59UK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
27/01/202208h00UK RegulatoryApollon Formularies plc Chief Science Officer Appointed as Board DirectorAQSE:APOLApollon Formularies plc
 Showing the most relevant articles for your search:AQSE:APOL

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
EU
BNP
BNP Paribas
EU
RNO
Renault
EU
HO
Thales
NASDAQ
AMZN
Amazon.com
EU
VK
Vallourec
EU
GLE
Societe Generale
EU
VIV
Vivendi
EU
BN
Danone
NYSE
JPM
JP Morgan Chase
EU
RI
Pernod Ricard
EU
PX4
SBF 120
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés